TNR states, Global Patented Drugs Market was Valued USD 813.9 Bn in 2022, Anticipated to Reach USD 1,359 Bn by 2031, Growing With a CAGR of 6.2% (2023-2031)

Patented drugs are a result of extensive research, development, and investment by pharmaceutical companies. The patent system is designed to encourage innovation by providing companies with a limited period of exclusivity during which they can recoup their investments and make a profit. This exclusivity allows them to charge higher prices for the drug to cover the costs of research and development.

Global Patented Drugs Market Revenue & Forecast, (US$ Million), 2015 – 2031

This growing pattern is linked to a limited number of developing, proprietary drugs with quick adoption and high year-over-year price increases, which are more than balancing the steady expansion in generic drug use. These higher prices are borne by both consumers and payers; whereas consumer out-of-pocket expenses for prescription pharmaceuticals have increased by just 3% per year overall, they have increased by 18% per year for patented drugs. Current trends indicate that the significant growth in patented medicine pricing is likely to continue in the coming years.

Trends in the Global Patented Drugs Market

• In the last few years, partnerships between pharmaceutical companies, research institutions, and academia have accelerated drug discovery and development, leading to a higher number of patented drugs. For instance, a sub-licensing agreements has been signed with three Indian companies, Eugia, Hetero, and Dr. Reddy’s Laboratories, along with the Indonesian firm BrightGene by Medicines Patent Pool (MPP). The research and development as well as production of generic versions of Novartis’ cancer treatment drug Nilotinib, making certain cancer drugs more affordable and accessible to patients. The drug is administered for treating chronic myeloid leukaemia (CML), which is a kind of blood cancer.
• Immunotherapy approaches, including checkpoint inhibitors and CAR-T cell therapies, are revolutionizing cancer treatment and contributing to the growth of the patented drugs market. In addition, Merck & Co of the United States plans to patent a new version of its $20 billion cancer treatment Keytruda that can be administered under the skin, enabling it to safeguard its best-selling medication from competition as early as 2028. Thus with these factors the global patented drugs market will exponentially rise during the forecast period.

In the last few years, rise of patented drugs being sold on online pharmacies can be attributed to several factors that reflect changes in consumer behavior, advancements in technology, and the global pharmaceutical market. Pharmaceutical companies are partnering with online pharmacies to directly market and distribute their products to consumers, expanding their reach beyond traditional distribution channels. Thus due to favorable reasons such as competitive pricing, variety of medications as well as direct-to-consumer marketing are all supporting the growth of the global patented drugs market.

The rising prominence of patented drugs in Asia can be attributed to several factors that reflect the region’s increasing investment in research and development, changing demographics, economic growth, and evolving healthcare systems. Asian countries are increasingly focusing on biotechnology and life sciences, which includes areas like genomics, proteomics, and personalized medicine. This shift has led to the development of more complex and targeted therapies that are often eligible for patent protection contributing to the overall growth of the global patented drugs market.

Competitive Landscape

The competitive landscape in the global patented drugs market is dynamic and shaped by various factors, including innovation, research and development, market share, pricing strategies, regulatory environment, and strategic partnerships.  Large pharmaceutical companies such as Pfizer, Roche, Novartis, Johnson & Johnson & AstraZeneca, among others, dominate the market. These companies invest heavily in research and development to bring innovative drugs to market and maintain a competitive edge. A few of key market participants operating in the global patented drugs market are:

• AbbVie Inc.
• Astellas Pharma Inc.
• AstraZeneca plc
• Bayer
• Biogen
• Boehringer Ingelheim International GmbH.
• F. Hoffmann-La Roche AG
• Gilead Sciences Inc
• Helsinn
• Johnson & Johnson
• Novartis AG
• Pf Prism Cv
• Pfizer Inc.
• Viiv
• Other Industry Participants

Global Patented Drugs Market Report Coverage

Global Patented Drugs Market

By Type

• Small Molecule Drugs
• Biologics
• Vaccines
• Gene Therapies
• Antiviral Drugs
• Anti-inflammatory Drugs
• Neurological Drugs
• Cancer Drugs
• Cardiovascular Drugs
• Others

By Distribution Channel

• Hospital Pharmacies
• Drug Stores and Retail Stores
• Online Pharmacies

By Region

• North America (U.S., Canada, Mexico, Rest of North America)
• Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
• Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
• Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
• Latin America (Brazil, Argentina, Rest of Latin America)

Report Coverage and Deliverables: 

Table of Contents

.

.

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

.

**Exclusive for Multi-User and Enterprise User.

.

Global Patented Drugs Market Segmentation

Global Patented Drugs Market – Type Outlook (Revenue, USD Million, 2015 – 2031)

**Note: The report covers cross-segmentation analysis by region further into countries

The Niche Research approach encompasses both primary and secondary research methods to provide comprehensive insights. While primary research is the cornerstone of our studies, we also incorporate secondary research sources such as company annual reports, premium industry databases, press releases, industry journals, and white papers.

Within our primary research, we actively engage with various industry stakeholders, conducting paid interviews and surveys. Our meticulous analysis extends to every market participant in major countries, allowing us to thoroughly examine their portfolios, calculate market shares, and segment revenues.

Our data collection primarily focuses on individual countries within our research scope, enabling us to estimate regional market sizes. Typically, we employ a bottom-up approach, meticulously tracking trends in different countries. We analyze growth drivers, constraints, technological innovations, and opportunities for each country, ultimately arriving at regional figures.Our process begins by examining the growth prospects of each country. Building upon these insights, we project growth and trends for the entire region. Finally, we utilize our proprietary model to refine estimations and forecasts.

Our data validation standards are integral to ensuring the reliability and accuracy of our research findings. Here’s a breakdown of our data validation processes and the stakeholders we engage with during our primary research:

• Supply Side Analysis: We initiate a supply side analysis by directly contacting market participants, through telephonic interviews and questionnaires containing both open-ended and close-ended questions. We gather information on their portfolios, segment revenues, developments, and growth strategies.
• Demand Side Analysis: To gain insights into adoption trends and consumer preferences, we reach out to target customers and users (non-vendors). This information forms a vital part of the qualitative analysis section of our reports, covering market dynamics, adoption trends, consumer behavior, spending patterns, and other related aspects.
• Consultant Insights: We tap into the expertise of our partner consultants from around the world to obtain their unique viewpoints and perspectives. Their insights contribute to a well-rounded understanding of the markets under investigation.
• In-House Validation: To ensure data accuracy and reliability, we conduct cross-validation of data points and information through our in-house team of consultants and utilize advanced data modeling tools for thorough verification.

The forecasts we provide are based on a comprehensive assessment of various factors, including:

• Market Trends and Past Performance (Last Five Years): We accurately analyze market trends and performance data from preceding five years to identify historical patterns and understand the market’s evolution.
• Historical Performance and Growth of Market Participants: We assess the historical performance and growth trajectories of key market participants. This analysis provides insights into the competitive landscape and individual company strategies.
• Market Determinants Impact Analysis (Next Eight Years): We conduct a rigorous analysis of the factors that are projected to influence the market over the next eight years. This includes assessing both internal and external determinants that can shape market dynamics.
• Drivers and Challenges for the Forecast Period:Identify the factors expected to drive market growth during the forecast period, as well as the challenges that the industry may face. This analysis aids in deriving an accurate growth rate projection.
• New Acquisitions, Collaborations, or Partnerships: We keep a close watch on any new acquisitions, collaborations, or partnerships within the industry. These developments can have a significant impact on market dynamics and competitiveness.
• Macro and Micro Factors Analysis:A thorough examination of both macro-level factors (e.g., economic trends, regulatory changes) and micro-level factors (e.g., technological advancements, consumer preferences) that may influence the market during the forecast period.
• End-User Sentiment Analysis: To understand the market from the end-user perspective, we conduct sentiment analysis. This involves assessing the sentiment, preferences, and feedback of the end-users, which can provide valuable insights into market trends.
• Perspective of Primary Participants: Insights gathered directly from primary research participants play a crucial role in shaping our forecasts. Their perspectives and experiences provide valuable qualitative data.
• Year-on-Year Growth Trend: We utilize a year-on-year growth trend based on historical market growth and expected future trends. This helps in formulating our growth projections, aligning them with the market’s historical performance.

Research process adopted by TNR involves multiple stages, including data collection, validation, quality checks, and presentation. It’s crucial that the data and information we provide add value to your existing market understanding and expertise. We have also established partnerships with business consulting, research, and survey organizations across regions and globally to collaborate on regional analysis and data validation, ensuring the highest level of accuracy and reliability in our reports.